The Osteoporosis Drugs Market To Witness Strengthening Of The Stability Plank With US$14,786.7 Mn

1
Osteoporosis Drugs Market
Report Id PMRREP2983 Category Life Science
Healthcare
2
About Persistence Market Research
Customized Research
Persistence Market Research(Persistence Market
Research) is a premier provider of syndicated
research reports, custom research reports, and
consulting services. We deliver a complete
packaged solution, which combines current market
intelligence, statistical anecdotes, technology
inputs, valuable growth insights, aerial view of
the competitive framework, and future market
trends. We provide research services at a global
as well as regional level key regions include
GCC, ASEAN, and BRIC. Our offerings cover a broad
spectrum of industries including Chemicals,
Materials, Energy, Technology, Healthcare, and
Retail. We have a global presence with delivery
centers across India specializing in providing
global research reports and country research
reports. Persistence Market Research is
headquartered out of London, U.K., with a
state-of-the-art delivery center located in Pune,
India. We combine our knowledge and learning from
every corner of the world to distill it to one
thing the perfect solution for our client.
Syndicated Research
Investment Research
Social Media Research
Research Capabilities
Sector Coverage

• Customized Research
• Syndicated Research
• Investment Research
• Social Media Research

• Automotive and Transportation
• Electronics, Semiconductor, and ICT
• Retail and Consumer Products
• Industrial Automation and Equipment

• Chemicals Materials
• Food and Beverages
• Services and Utilities
• Energy, Mining, Oil, and Gas

Subscription Information
For detailed subscription information please
contact Website www.persistencemarketresearch.co
m For sales queries or new topics email us on
sales_at_persistencemarketresearch.com
3
The Osteoporosis Drugs Market To Witness
Strengthening Of The Stability Plank With
US14,786.7 Mn

• According to a new market report published by
  Persistence Market Research Global Market Study
  on Osteoporosis Drugs AsiaPacific to Witness
  Highest Growth by 2022, the global osteoporosis
  drugs market is estimated to be valued
  at US11,226.1 Mn by the end of 2015 and is
  expected to expand at a CAGR of 4.0 from 2014 to
  2022, to account for US14,786.7 Mn by 2022.
• The global osteoporosis drugs market is
  witnessing significant growth due to rising
  geriatric population and changing lifestyles
  impinging bone health. Prevalence of osteoporosis
  is high among people aged 60 years and above.
  Moreover, increasing the prevalence of
  osteoporosis in postmenopausal women, growing
  awareness about osteoporotic care, and increasing
  investment in drug discovery and development are
  also driving the growth of the market.

Get Sample Copy of Report _at_ https//www.persistenc
emarketresearch.com/samples/2983
4
Want to know more about this report

• In North America, the prevalence of osteoporosis
  is high primarily due to increasing geriatric
  population, growing obesity, and rising
  prevalence of lifestyle associated diseases in
  the region. According to the National
  Osteoporosis Foundation, in 2013, approximately
  54 million people in the U.S. aged 50 years and
  above were affected by osteoporosis and low bone
  mass. According to the U.S. Department of Health
  and Human Services, in the U.S., approximately
  250,000 hip fractures are associated with
  osteoporosis.
• In Europe, increasing aging population, changing
  lifestyles, and increasing consumer awareness
  about osteoporosis care are driving the growth of
  the osteoporosis drug market. According to the
  International Osteoporosis Foundation,
  approximately 5.5 million men and 22 million
  women suffered from osteoporosis in 2010.
  Moreover, according to International Osteoporosis
  Foundation, approximately 27.5 million people in
  Europe suffered from osteoporosis in 2010 and the
  number is expected to reach 33.9 Mn by 2030.
• However, the growth of osteoporosis market in
  Asia Pacific is much due to rising geriatric
  population and changing lifestyles in the region.
  Osteoporotic patients have a higher risk of hip
  fractures, owing to a major cause of morbidity
  and mortality.

Access Full Report _at_ https//www.persistencemarket
research.com/checkout/2983
5
(No Transcript)